OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	explicit_question

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2290997	4/2008	S16-PMC2290997	['ALTHOUGH most of the health-promoting benefits of sun exposure are THOUGHT TO occur through Vitamin D Photosynthesis, there MAY BE OTHER health benefits that have gone largely OVERLOOKED in the DEBATE over HOW much sun is NEEDED for good health [see “other sun-dependent pathways,” p. a165].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('EXPLICIT_QUESTION', 206), ('IMPORTANT_CONSIDERATION', 222)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 102, 'photosynthesis')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC2290997	4/2008	S80-PMC2290997	['researchers are now seeking to understand HOW much uvr/Vitamin D is NEEDED to lower the risk of diabetes and WHETHER this is a FACTOR ONLY in high-risk groups.']	[('EXPLICIT_QUESTION', 42), ('FUTURE_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('EXPLICIT_QUESTION', 109), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 134)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2290997	4/2008	S182-PMC2290997	['moreover, it is not at all clear WHEN, over a lifetime, sun exposure/Vitamin D is most IMPORTANT.']	[('EXPLICIT_QUESTION', 33), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC2582131	11/2008	S127-PMC2582131	['IF CONFIRMED, our data RAISE the POSSIBILITY that treating Vitamin D deficiency in Pregnancy, via supplementation OR lifestyle measures, CAN CONTRIBUTE to the PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('EXPLICIT_QUESTION', 23), ('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]
PMC2779500	11/2009	S44-PMC2779500	['THESE FINDINGS, among others, UNDOUBTEDLY necessitate CONCERN, and have led authors to QUESTION the benefits of universal Vitamin A supplementation for women in hiv-endemic areas [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 30), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('EXPLICIT_QUESTION', 87)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC2798111	12/2010	S20-PMC2798111	['the revised statement by the american academy of pediatrics [26] brings forth the QUESTION of WHETHER OR NOT Vitamin D-only preparations are as effective as the time-honored use of infant multivitamin preparations in achieving adequate Vitamin D status in breastfed infants.']	[('EXPLICIT_QUESTION', 82), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	2	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC2798111	12/2010	S98-PMC2798111	['UNTIL it can be determined WHAT amount of Vitamin D supplementation in mothers will effectively and SAFELY increase and/or maintain the Vitamin D status in her breastfed infant, we MUST rely on Vitamin D supplementation of the infant to prevent deficiency.']	[('FUTURE_WORK', 0), ('EXPLICIT_QUESTION', 27), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC2821652	2/2010	S75-PMC2821652	['THEREFORE, we were faced with the CHALLENGE of establishing novel criteria for Vitamin D supplement adherence by Serum 25(Oh)D levels; HOW we arrived at this definition is described below.']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 34), ('EXPLICIT_QUESTION', 135)]	3	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 121, '(OH ... D')]
PMC2821652	2/2010	S77-PMC2821652	["in developing a definition of adherence by Serum 25(Oh)D levels, SEVERAL ASSUMPTIONS were made a priori about WHAT types of PATTERNS of 25(Oh)D levels would be exhibited by adherent and nonadherent patients BASED ON CURRENT KNOWLEDGE about the Metabolism Of Vitamin D.\nassumption 1\nBASED ON KNOWN pharmacokinetics of Vitamin D [64], adherent patients' 25(Oh)D levels would be expected to rise over time, eventually reaching a steady state after 2 months of therapy; nonadherent patients' 25(Oh)D levels would be expected to be erratic and to exhibit variable PATTERNS that would differ significantly from adherent patients' 25(Oh)D levels over the same dosing interval."]	[('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('EXPLICIT_QUESTION', 110), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 207), ('PROBABLE_UNDERSTANDING', 207), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 216), ('PROBABLE_UNDERSTANDING', 282), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 559)]	12	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 244, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 317, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 325, 'D'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 358, 'D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 488, '25'), ('PR_000011614', 'opioid growth factor receptor', 491, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 494, 'D'), ('CHEBI_71657', 'versiconol acetate', 624, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 624, '25(OH ... D')]
PMC2889879	5/2010	S14-PMC2889879	['conclusion\nOUR FINDINGS RAISE a POSSIBILITY that Adult women with a high Intake of fish, Omega-3 or Omega-6 Pufa and Vitamin D have a lower rate of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('EXPLICIT_QUESTION', 24), ('INCOMPLETE_EVIDENCE', 32)]	3	[('UBERON_0007023', 'adult organism', 49, 'adult'), ('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_79370', 'ibho#10', 89, 'omega-3'), ('CHEBI_79370', 'ibho#10', 100, 'omega-6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 108, 'PUFA'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC2898025	5/2010	S113-PMC2898025	['seasonal variation in Vitamin D levels also HAS BEEN SUGGESTED as a factor differentially AFFECTING newborn Growth Plate width, and this MAY explain WHY babies Born in australia around october (spring) are relatively heavier than those Born at other times [156].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 137), ('EXPLICIT_QUESTION', 149)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002516', 'epiphyseal plate', 108, 'growth plate'), ('GO_0007567', 'parturition', 160, 'born'), ('GO_0007567', 'parturition', 236, 'born')]
PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
PMC2963768	10/2010	S87-PMC2963768	['to put these FINDINGS in a global context, it is first useful to draw a comparison with WHAT is PERHAPS the ONLY young infant ‘reference’ group studied at the equator where Vitamin D status would be expected to be optimal throughout the year in the absence of dietary supplementation or fortification.']	[('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 88), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 108)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3004407	12/2010	S12-PMC3004407	['THESE FINDINGS RAISE the ISSUE of adequacy of current Vitamin D RECOMMENDATIONS for Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 15), ('PROBLEM_COMPLICATION', 25), ('FUTURE_WORK', 64)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC3075531	7/2010	S46-PMC3075531	['the REASONS WHY Vitamin D deficiency is THOUGHT TO be a RISK FACTOR for ms are as follows: first, ms frequency increases with increasing latitude, which is strongly inversely CORRELATED with duration and intensity of uvb from sunlight and Vitamin D concentrations.2830–35second, prevalence of ms is lower than EXPECTED at high latitudes in populations with high Consumption of Vitamin-D-rich Fatty fish43536.']	[('PROBABLE_UNDERSTANDING', 4), ('EXPLICIT_QUESTION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 310)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0007631', 'feeding behavior', 362, 'consumption'), ('CHEBI_83326', 'tedizolid phosphate', 377, 'vitamin-D'), ('CHEBI_33250', 'atom', 392, 'fatty')]
PMC3271033	1/2012	S137-PMC3271033	['THEREFORE, in considering early Vitamin D supplementation, the QUESTION becomes WHETHER there is physiological BENEFIT to rapid replenishment with Vitamin D (e.g.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 63), ('EXPLICIT_QUESTION', 80), ('IMPORTANT_CONSIDERATION', 111)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3277098	12/2011	S26-PMC3277098	['ALTHOUGH often not significant in terms of rickets or osteomalacia, it REMAINS UNKNOWN WHAT, if any, are the clinical outcomes of Vitamin D insufficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 71), ('EXPLICIT_QUESTION', 87)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
PMC3296991	2/2012	S21-PMC3296991	['HOWEVER, there are gaps in the understanding of WHETHER AND HOW Vitamin D INFLUENCES fetal Bone Development and WHETHER markers of bone turnover in Cord Blood PREDICT bone Mineral content.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('EXPLICIT_QUESTION', 48), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('EXPLICIT_QUESTION', 112), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0048539', 'bone marrow development', 91, 'bone development'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_46662', 'mineral', 172, 'mineral')]
PMC3309463	6/2011	S89-PMC3309463	['with respect to the epidemiology of schizophrenia, we OUTLINE HOW one CANDIDATE environmental RISK FACTOR, low Prenatal Vitamin D, CAN result in environmental editing of Brain Development.']	[('INCOMPLETE_EVIDENCE', 54), ('EXPLICIT_QUESTION', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 131)]	5	[('GO_0007565', 'female pregnancy', 111, 'prenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007420', 'brain development', 170, 'brain development'), ('UBERON_0000955', 'brain', 170, 'brain')]
PMC3347028	3/2012	S17-PMC3347028	['in the sections ahead, we will FOCUS on one Micronutrient—Vitamin D—and will discuss WHAT we KNOW and what we surely do NOT KNOW in the context of the Pregnant woman and her developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('EXPLICIT_QUESTION', 85), ('INCOMPLETE_EVIDENCE', 93), ('FULL_UNKNOWN', 120)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 44, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant')]
PMC3347028	3/2012	S18-PMC3347028	['during this foray into the world of Vitamin D and the fetus, we MUST first define WHAT Vitamin D is, WHAT it is not, and review the Metabolic pathways LINKED with Vitamin D.\n\n2.']	[('IMPORTANT_CONSIDERATION', 64), ('EXPLICIT_QUESTION', 82), ('EXPLICIT_QUESTION', 101), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 132, 'metabolic'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3347028	3/2012	S140-PMC3347028	['for those areas of the world with higher rates of deficiency, it APPEARS that a long-standing unawareness of HOW Vitamin D is made and of the short and long-term health CONSEQUENCES of Vitamin D insufficiency has LED TO widespread insufficiencies in most populations.']	[('ANOMALY_CURIOUS_FINDING', 65), ('EXPLICIT_QUESTION', 109), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 213)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S143-PMC3347028	['from the prior sections, IT IS CLEAR that Vitamin D deficiency during Pregnancy is common throughout the world YET WHAT EFFECT does deficiency have on the mother and her developing fetus?']	[('PROBABLE_UNDERSTANDING', 25), ('ANOMALY_CURIOUS_FINDING', 111), ('EXPLICIT_QUESTION', 115), ('SUPERFICIAL_RELATIONSHIP', 120), ('EXPLICIT_QUESTION', 186)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3347028	3/2012	S177-PMC3347028	['in addition, WHAT amount of sunlight is sufficient to achieve optimal Vitamin D status varies DEPENDING ON a host of FACTORS such as the time of day, the time of year, the latitude, degree of skin pigmentation, type and extend of clothing, body surface area exposed and one’s body mass index (bmi) [146].']	[('EXPLICIT_QUESTION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3347028	3/2012	S217-PMC3347028	['studies specifically designed and powered to answer the QUESTION of WHETHER OR NOT Vitamin D supplementation LEADS TO improved health outcomes—lower RISK of Preterm Birth, preeclampsia, and infection REMAIN to be done.']	[('EXPLICIT_QUESTION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 200)]	5	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'preterm birth')]
PMC3347028	3/2012	S220-PMC3347028	['unanswered questions and direction of FUTURE RESEARCH endeavors\nthere are many UNANSWERED QUESTIONS about Vitamin D’s “true” ROLE during Pregnancy: at no other time during the Lifecycle is 25(Oh)D so closely LINKED with 1,25(Oh)2D [6].']	[('FUTURE_WORK', 38), ('ANOMALY_CURIOUS_FINDING', 79), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0000104', 'life cycle', 176, 'lifecycle'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 222, '25(OH)2D')]
PMC3347028	3/2012	S227-PMC3347028	['IS Vitamin D merely a marker of synergistic processes within the body?']	[('EXPLICIT_QUESTION', 0), ('EXPLICIT_QUESTION', 69)]	2	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D')]
PMC3347028	3/2012	S228-PMC3347028	['IS it a constellation of FACTORS such as Vitamin D acting in concert with Vitamin A to create a healthful milieu?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('EXPLICIT_QUESTION', 112)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC3347028	3/2012	S229-PMC3347028	['WHAT about the interplay between genetics, epigenetics and daily fluxes in Vitamin D status?']	[('EXPLICIT_QUESTION', 0), ('EXPLICIT_QUESTION', 91)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3347028	3/2012	S230-PMC3347028	['ARE those at greatest risk for Vitamin D deficiency somehow PROTECTED by selective differences in Vitamin D binding protein affinities and in the Vitamin D receptor itself?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('EXPLICIT_QUESTION', 171)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3347028	3/2012	S231-PMC3347028	['IF so, does substrate sufficiency—EITHER through adequate sunlight exposure OR Vitamin D supplementation—saturate such EFFECTS, making them clinically irrelevant?']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 119), ('EXPLICIT_QUESTION', 161)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3347028	3/2012	S232-PMC3347028	['WHAT about Vitamin D’s ROLE in maintaining Immune Homeostasis during Pregnancy?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 43, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 43, 'immune'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC3347028	3/2012	S233-PMC3347028	['looking carefully at the INCREASING NUMBER OF epidemiological STUDIES involving women with Preeclampsia: is there a LINK with Vitamin D deficiency where PERHAPS in certain women, there is loss of the Vitamin D-mediated Suppression Of T Cells that leads to a profound inflammatory reaction REMINISCENT of graft- vs. -host disease?']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 289), ('EXPLICIT_QUESTION', 328)]	6	[('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0048469', 'cell maturation', 219, 'suppression of T cells'), ('CL_0000084', 'T cell', 234, 'T cells')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3417531	7/2012	S66-PMC3417531	["(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?"]	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC3471827	10/2012	S18-PMC3471827	['after DEMONSTRATING the Embryonic requirement for Vitamin E we next queried HOW Α-Tocopherol is transferred into the Embryo during development.']	[('INCOMPLETE_EVIDENCE', 6), ('EXPLICIT_QUESTION', 76)]	2	[('UBERON_0000922', 'embryo', 24, 'embryonic'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E'), ('CHEBI_27725', 'butin', 80, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 117, 'embryo')]
PMC3471827	10/2012	S105-PMC3471827	['the phenotype, especially impaired Brain Formation in ttp knockdown Zebrafish Embryos RAISES the INTRIGUING POSSIBILITY that low Vitamin E status has adverse events in early Central Nervous System development in other Animals, including Humans.']	[('EXPLICIT_QUESTION', 86), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 108)]	3	[('GO_0001503', 'ossification', 35, 'brain formation'), ('UBERON_0000955', 'brain', 35, 'brain'), ('NCBITaxon_7955', 'Danio rerio', 68, 'zebrafish'), ('UBERON_0000922', 'embryo', 78, 'embryos'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 174, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 174, 'central nervous system'), ('NCBITaxon_33208', 'Metazoa', 218, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'humans')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3501517	11/2012	S214-PMC3501517	['we chose this MODEL because we were primarily interested in HOW Vitamin D level AFFECTED inflammatory response and resolution of inflammation RATHER than bacterial or Viral clearance.']	[('INCOMPLETE_EVIDENCE', 14), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_1', 'root', 167, 'viral')]
PMC3501517	11/2012	S218-PMC3501517	['WHETHER Vitamin D Modulates Neutrophil function with infectious pneumonia REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('FULL_UNKNOWN', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0065007', 'biological regulation', 18, 'modulates'), ('CL_0000775', 'neutrophil', 28, 'neutrophil')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3613945	2/2013	S3-PMC3613945	['WHETHER these variants also INFLUENCE the ROLE of Vitamin D in an Immunologic milieu is NOT KNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 88)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000913', 'interstitial fluid', 66, 'immunologic')]
PMC3629265	4/2013	S89-PMC3629265	['this RAISES the QUESTION of WHETHER 400 iu of Vitamin D per litre of formula is SUFFICIENT.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('EXPLICIT_QUESTION', 28), ('IMPORTANT_CONSIDERATION', 80)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3659910	1/2013	S16-PMC3659910	['[1] the QUESTION scientists HAVE BEEN working on for almost a decade is WHY and HOW Vitamin D is AFFECTING Conception, Pregnancy and the health of the newborn.']	[('EXPLICIT_QUESTION', 8), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 72), ('EXPLICIT_QUESTION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	5	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007620', 'copulation', 107, 'conception'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3659910	1/2013	S17-PMC3659910	['[2] also the media has been taking increasing INTEREST, and public EXPECTATIONS have been RAISED regarding the enhanced ROLES for Vitamin D in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('FUTURE_PREDICTION', 67), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC3659910	1/2013	S77-PMC3659910	['for Vitamin D, there are STILL underlying QUESTIONS: HOW much is the daily REQUIREMENT and HOW much is too much?']	[('IMPORTANT_CONSIDERATION', 25), ('EXPLICIT_QUESTION', 42), ('EXPLICIT_QUESTION', 53), ('IMPORTANT_CONSIDERATION', 75), ('EXPLICIT_QUESTION', 91), ('EXPLICIT_QUESTION', 111)]	6	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC3659910	1/2013	S133-PMC3659910	['BECAUSE the POOR Vitamin D stores of the mother MAY impair Vitamin D state in the infant, it is IMPORTANT to know WHETHER rickets can be PREVENTED in breast Fed infants by supplementation of the mother.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 96), ('EXPLICIT_QUESTION', 114), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'fed')]
PMC3672018	5/2013	S45-PMC3672018	['furthermore, large-scale interventional STUDIES ARE NEEDED to examine HOW Vitamin D exposure during Pregnancy AFFECTS long-term health outcomes of offspring.']	[('FUTURE_WORK', 40), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 110)]	3	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC3672018	5/2013	S167-PMC3672018	['THUS, AS IT IS CLEAR that Vitamin D status of danes NEEDS to be improved, the danish health authorities currently DEBATE, WHETHER to resume Vitamin D fortification of Food [35].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_33290', 'food', 167, 'food')]
PMC3672018	5/2013	S180-PMC3672018	['besides IMPLICATIONS for research in the field, it MAY also inform the current DEBATE in denmark on WHETHER to resume Vitamin D Food fortification.']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('EXPLICIT_QUESTION', 100)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 128, 'food')]
PMC3702245	6/2013	S16-PMC3702245	['high prevalence of low Vitamin D intake in Pregnancy\nthe Vitamin D status in Adults, including Pregnant women, is based currently on measurement of Serum 25(Oh)D concentrations, BUT WHAT constitutes the “normal” OR “optimal” level is CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('EXPLICIT_QUESTION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_63056', 'zinc cation', 154, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 160, 'D')]
PMC3702245	6/2013	S71-PMC3702245	['as mentioned earlier, the criteria for defining WHAT constitutes “normal” Vitamin D status are CONTROVERSIAL.']	[('EXPLICIT_QUESTION', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
PMC3705146	5/2013	S37-PMC3705146	['clearly, the relative lack of sunlight had an evolutionary IMPACT on Genes AFFECTING Vitamin D generation from sunlight, BUT WHAT EVIDENCE is there that it MIGHT also have selected for a change in the prevalence of a disease such as schizophrenia?']	[('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('EXPLICIT_QUESTION', 125), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 156), ('EXPLICIT_QUESTION', 246)]	7	[('SO_0000704', 'gene', 69, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
PMC3713405	7/2013	S157-PMC3713405	['HOW the absence (or presence) of Vitamin D COULD alter nurr1 levels REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 43), ('FULL_UNKNOWN', 68)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3717170	5/2013	S165-PMC3717170	['UNFORTUNATELY, the QUESTION of WHETHER Vitamin D PREVENTS OR slows Aging cannot be easily tested.']	[('IMPORTANT_CONSIDERATION', 0), ('EXPLICIT_QUESTION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007568', 'aging', 67, 'aging')]
PMC3717170	5/2013	S168-PMC3717170	['shifting attention from Aging to the Aging phenotype, the QUESTION of WHETHER Vitamin D AFFECTS major Aging phenotypes becomes more approachable.']	[('EXPLICIT_QUESTION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 88)]	4	[('GO_0007568', 'aging', 24, 'aging'), ('GO_0007568', 'aging', 37, 'aging'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007568', 'aging', 102, 'aging')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC3717170	5/2013	S206-PMC3717170	['conclusions\nthe conference “Vitamin D: beyond bone” explo-red a considerable range of functions for Vitamin D and POTENTIAL therapeutic IMPLICATIONS outside of Calcium Homeostasis and bone health, HIGHLIGHTING the INCREASED UNDERSTANDING of Vitamin D, as well as HOW much is yet to be Learned.']	[('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 214), ('EXPLICIT_QUESTION', 263)]	5	[('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 28, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 160, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007612', 'learning', 285, 'learned')]
PMC3717763	8/2013	S0-PMC3717763	['a qualitative study of uptake of free Vitamins in england\n\nabstract\n\nobjective\nTO IDENTIFY reasons WHY eligible families are not accessing free ‘healthy start’ Vitamin supplementation (providing Vitamins A, C and d) in england.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('EXPLICIT_QUESTION', 99)]	2	[('CHEBI_33277', 'gamma-tocotrienol', 38, 'vitamins'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin'), ('CHEBI_27300', 'vitamin D', 195, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 204, 'A'), ('PR_000004900', 'complement C3', 207, 'C')]
PMC3717763	8/2013	S18-PMC3717763	["in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england."]	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
PMC3728489	7/2013	S311-PMC3728489	['Vitamin D\nwe have DESCRIBED earlier HOW Vitamin D is PIVOTAL in early Immune Development and it is also known to be CRUCIAL for early Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 18), ('EXPLICIT_QUESTION', 36), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001822', 'kidney development', 70, 'immune development'), ('UBERON_0002405', 'immune system', 70, 'immune'), ('GO_0001501', 'skeletal system development', 134, 'skeletal development'), ('UBERON_0004288', 'skeleton', 134, 'skeletal')]
PMC3773018	4/2013	S92-PMC3773018	['there is no gold standard for HOW to define low Vitamin D status at Birth and in early childhood.']	[('EXPLICIT_QUESTION', 30)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'birth')]
PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC3814422	10/2013	S1-PMC3814422	['the epidemiological EVIDENCE TO SUPPORT these CLAIMS is CONFLICTING and MAY reflect chance FINDINGS and differences in HOW Vitamin D was assessed.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 91), ('EXPLICIT_QUESTION', 119)]	7	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3814422	10/2013	S20-PMC3814422	['factors such as residual CONFOUNDING, chance results attributable to SMALL sample sizes and differences in HOW Vitamin D exposure and childhood outcomes were measured (i.e.']	[('PROBLEM_COMPLICATION', 25), ('INCOMPLETE_EVIDENCE', 69), ('EXPLICIT_QUESTION', 107)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC3873449	12/2013	S137-PMC3873449	['HOW much sun exposure results in adequate Vitamin D Synthesis?']	[('EXPLICIT_QUESTION', 0), ('EXPLICIT_QUESTION', 61)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 52, 'synthesis')]
PMC3873449	12/2013	S142-PMC3873449	['in beijing (39.9°n), china, HOW much sunlight exposure is needed for women to form sufficient Vitamin D in winter?']	[('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 113)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3991049	11/2013	S80-PMC3991049	['we NEED rct of Vitamin D supplementation with measurement of 25-Hydroxyvitamin D to determine the baseline status, the level achieved on supplementation with appropriate design to avoid any CONFOUNDER, and TO ASSESS WHAT is the appropriate level of Vitamin D during Pregnancy and in newborns with no complications or toxicity through out.']	[('FUTURE_WORK', 3), ('PROBLEM_COMPLICATION', 190), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('EXPLICIT_QUESTION', 216)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC4072587	6/2014	S121-PMC4072587	['our finding of an ASSOCIATION between maternal Vitamin D and infant Language composite scores, that was ONLY observed when maternal Vitamin D levels fell below 37.5 nmol/l in late Pregnancy, RAISES the POSSIBILITY that there is a threshold EFFECT, and that Language impairment is a feature of more marked Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 191), ('INCOMPLETE_EVIDENCE', 202), ('SUPERFICIAL_RELATIONSHIP', 240)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0006266', 'DNA ligation', 68, 'language'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('GO_0006266', 'DNA ligation', 257, 'language'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4113768	7/2014	S148-PMC4113768	['2012, 67 , 1139-1144), NO PUBLISHED research has specifically examined WHETHER there is a LINK between Vitamin D and Sleep.']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('EXPLICIT_QUESTION', 71), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0030431', 'sleep', 117, 'sleep')]
PMC4113768	7/2014	S370-PMC4113768	['dissection: SHOULD we spend resources on testing Vitamin D level or treat universally?']	[('EXPLICIT_QUESTION', 12), ('EXPLICIT_QUESTION', 85)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S371-PMC4113768	['HOW HARD should we fight for improved affordable access to daily Vitamin D supplementation?']	[('EXPLICIT_QUESTION', 0), ('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 90)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 73, 'D')]
PMC4113768	7/2014	S378-PMC4113768	['the national academies press : washington, dc, usa, 2011).we INVESTIGATED WHETHER DIFFERENT levels of habitual Calcium Intake INFLUENCED Serum 25(Oh)D and indices of Vitamin D activation and Catabolism during winter and in the context of both adequate and inadequate Vitamin D intakes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('EXPLICIT_QUESTION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007631', 'feeding behavior', 119, 'intake'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 143, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009056', 'catabolic process', 191, 'catabolism'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4113768	7/2014	S829-PMC4113768	['the staff were asked WHETHER they knew WHY Vitamin D is IMPORTANT, WHO should BE offered Vitamin D supplementation and at WHAT dose.']	[('EXPLICIT_QUESTION', 21), ('EXPLICIT_QUESTION', 39), ('IMPORTANT_CONSIDERATION', 56), ('EXPLICIT_QUESTION', 67), ('ANOMALY_CURIOUS_FINDING', 78), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S835-PMC4113768	['only 40% women could give a REASON WHY Vitamin D supplements were IMPORTANT- all of them had taken Supplements.']	[('PROBABLE_UNDERSTANDING', 28), ('EXPLICIT_QUESTION', 35), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 99, 'supplements')]
PMC4113768	7/2014	S838-PMC4113768	['staff: only 67% staff were able to answer WHY Vitamin D was IMPORTANT.']	[('EXPLICIT_QUESTION', 42), ('IMPORTANT_CONSIDERATION', 60)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S884-PMC4113768	['Sickle Cell patients frequently have low levels of Vitamin D. HOW significant is this vitaminin maintaining vertebral structure?']	[('EXPLICIT_QUESTION', 62), ('EXPLICIT_QUESTION', 127)]	2	[('CL_0000437', 'gonadtroph', 0, 'Sickle cell'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4113768	7/2014	S903-PMC4113768	['to WHAT degree does Vitamin D INFLUENCE Dental health in children?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 30), ('EXPLICIT_QUESTION', 65)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 40, 'dental')]
PMC4113768	7/2014	S1329-PMC4113768	['it is HYPOTHESISED that transient changes in Serum calcium MAY BE responsible for Remineralisation of marginally under-mineralised bone; and this MIGHT EXPLAIN WHY Vitamin D most benefits those who are AT RISK of deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 152), ('EXPLICIT_QUESTION', 160), ('IMPORTANT_CONSIDERATION', 202)]	6	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('GO_0031147', '1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process', 82, 'remineralisation'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4113768	7/2014	S1674-PMC4113768	['OUR FINDINGS RAISE the POSSIBILITY that Vitamin D deficiency MAY BE a consequence, as well as a cause, of active tuberculosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 61)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S2000-PMC4113768	['this RAISES the HYPOTHESIS that low Vitamin D is RELATED to POOR mental health in the Adult general population.']	[('EXPLICIT_QUESTION', 5), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 60)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adult')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4113768	7/2014	S2681-PMC4113768	['we were interested to see HOW this group of non-typical “patients” Vitamin D status compared with our local inner city birmingham gp population.']	[('EXPLICIT_QUESTION', 26)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S2725-PMC4113768	['OF CONCERN is that People taking 10,000 iu/day or less are SHOWING high to toxic levels of 25Ohd, ALTHOUGH we do NOT KNOW HOW many, if any, of these users are displaying signs of Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 3), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 98), ('FULL_UNKNOWN', 113), ('EXPLICIT_QUESTION', 122)]	6	[('NCBITaxon_10088', 'Mus <genus>', 19, 'people'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 91, '25OHD'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4231606	10/2013	S112-PMC4231606	['discussion\nthe PURPOSE of THIS STUDY was TO DETERMINE WHETHER children with s-ecc have different nutritional profiles THAN their caries-free peers, specifically Vitamin D, calcium and albumin status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('EXPLICIT_QUESTION', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	5	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4231606	10/2013	S122-PMC4231606	['regression techniques were employed to determine WHETHER the ASSOCIATION between caries and Vitamin D status REMAINED after controlling for CONFOUNDERS.']	[('EXPLICIT_QUESTION', 49), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 140)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4251419	12/2014	S116-PMC4251419	['we ANTICIPATE that a deeper understanding of HOW Vitamin D Modulates the microbiomes of the skin and other Tissues will come through ONGOING Vitamin D supplementation trials [74].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 3), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 133)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0065007', 'biological regulation', 59, 'modulates'), ('UBERON_0000479', 'tissue', 107, 'tissues'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4251419	12/2014	S122-PMC4251419	["WHY doesn't Vitamin D supplementation decrease disease RISKS?"]	[('EXPLICIT_QUESTION', 0), ('IMPORTANT_CONSIDERATION', 55), ('EXPLICIT_QUESTION', 60)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4251419	12/2014	S123-PMC4251419	["in the face of SUPPORTIVE OBSERVATIONAL and mechanistic EVIDENCE, WHY doesn't Vitamin D supplementation decrease disease RISKS?"]	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 56), ('EXPLICIT_QUESTION', 66), ('IMPORTANT_CONSIDERATION', 121), ('EXPLICIT_QUESTION', 126)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4256222	12/2014	S133-PMC4256222	['until 1995, we ONLY have access to diagnoses recorded during hospitalization, which MAY EXPLAIN WHY maternal Vitamin D status in our data is unassociated with offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 88), ('EXPLICIT_QUESTION', 96)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]
PMC4302429	1/2015	S192-PMC4302429	['one mechanism of HOW Vitamin D3 MIGHT act beneficially in infections, COULD BE an increase in pathogen Phagocytosis with adequate levels of Vitamin D [21] and the ability of Calcitriol to maintain Antimicrobial peptide Gene Expression [13,14].']	[('EXPLICIT_QUESTION', 17), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_33279', 'vitamin D5', 21, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 21, 'vitamin D3'), ('GO_0006909', 'phagocytosis', 103, 'phagocytosis'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 174, 'calcitriol'), ('CHEBI_65381', 'albizoside C', 197, 'antimicrobial'), ('GO_0010467', 'gene expression', 219, 'gene expression'), ('SO_0000704', 'gene', 219, 'gene')]
PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S59-PMC4380518	['we DID NOT HAVE DATA on WHETHER women were taking separate Calcium or Vitamin D supplements beyond what is contained in pnvs.']	[('FULL_UNKNOWN', 3), ('EXPLICIT_QUESTION', 24)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 59, 'calcium'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4383226	2/2015	S27-PMC4383226	['CLINICAL TRIALS ARE NOW NEEDED to CONFIRM these results and investigate HOW effectively Vitamin A prevents malaria.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 9), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 34), ('EXPLICIT_QUESTION', 72)]	5	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S103-PMC4383226	['it is UNCLEAR HOW Vitamin A COULD INTERACT with G6Pd to INFLUENCE the risk of malaria infection; the ONLY literature discussion regarding Vitamin A and G6Pd is LIMITED to Animal FINDINGS on Adipose and Lipogenic activities (higueret et al., 1989;arana et al., 2008).']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 14), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 178)]	8	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 48, 'G6PD'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 152, 'G6PD'), ('NCBITaxon_33208', 'Metazoa', 171, 'animal'), ('UBERON_2000251', 'adipose fin', 190, 'adipose'), ('GO_0008610', 'lipid biosynthetic process', 202, 'lipogenic')]
PMC4417995	4/2015	S153-PMC4417995	['the above data MAY EXPLAIN WHY skin infections occur more frequently in winter, when Keratinocytes are less stimulated by Vitamin D to produce Antimicrobial peptides.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 19), ('EXPLICIT_QUESTION', 27)]	3	[('CL_0000312', 'keratinocyte', 85, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 143, 'antimicrobial')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4448820	5/2015	S445-PMC4448820	['caption (table-wrap): table 5\n\nfunction of the major Acute Phase reactants1functionpositive\u2003α1-Acid Glycoprotein (agp/orm)Opsonin\u2003Α1-Antitrypsinserpin\u2003Α1-Glycoprotein (sap)Opsonin\u2003Α2-Macroglobulinserpin\u2003angiogeninangiogenesis\u2003Ceruloplasmin2Fe oxidation, Cu transport\u2003Complement Component 3Opsonin\u2003Complement Component 4 Binding proteinopsonin\u2003Complement Factor Bopsonin\u2003crpopsonin\u2003Ferritin2Fe Sequestration\u2003fibrinogencoagulation\u2003gc Globulin (Vitamin D Binding Protein)2complement activation, Vitamin D transport\u2003Haptoglobin2Fe Sequestration\u2003Hemopexin2Fe Sequestration\u2003Hepcidin Antimicrobial peptide2fe Sequestration\u2003Histidine-rich Glycoproteinhemostasis\u2003Lactoferrin2Fe Sequestration\u2003Lps binding proteinbacterial pattern recognition receptor\u2003Mannose-Binding Lectin (protein c) 2complement activation\u2003metallothionein2zn transport\u2003Serum Amyloid A1Chemoattractant\u2003Serum Amyloid a2unknown\u2003transcobalamin?2vitamin B-12 transport\u2003von Willebrand factorhemostasisnegative\u2003Albumin2Oncotic pressure, Lipid Transport\u2003α2-hs-glycoproteinca2+transport?']	[('EXPLICIT_QUESTION', 1036)]	1	[('GO_0006953', 'acute-phase response', 53, 'acute phase'), ('CHEBI_37527', 'acid', 95, 'Acid'), ('CHEBI_17089', 'glycoprotein', 100, 'glycoprotein'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 122, 'Opsonin α1'), ('PR_000029268', 'APC membrane recruitment protein 2', 133, 'AntitrypsinSerpin α1'), ('CHEBI_17089', 'glycoprotein', 154, 'Glycoprotein'), ('PR_000011609', 'teneurin-4', 172, 'Opsonin α2-MacroglobulinSerpin'), ('PR_000004876', 'complement C1q subcomponent subunit B', 226, 'Ceruloplasmin2Fe'), ('CHEBI_17996', 'chloride', 254, 'Cu'), ('PR_000005693', 'collagen alpha-1(X) chain', 267, 'Complement component 3Opsonin'), ('PR_000005591', 'battenin', 297, 'Complement component 4 binding'), ('GO_0032991', 'protein-containing complex', 308, 'component 4'), ('PR_000003266', 'collagen type II alpha chain', 343, 'Complement factor BOpsonin'), ('PR_000007443', 'Fc receptor-like protein 4', 381, 'Ferritin2Fe'), ('GO_0051235', 'maintenance of location', 393, 'sequestration'), ('CHEBI_5386', 'globin', 432, 'globulin'), ('PR_000008286', 'serine/threonine-protein kinase haspin', 432, 'globulin ...'), ('CHEBI_27300', 'vitamin D', 442, 'vitamin D'), ('PR_000017313', 'pantetheinase', 442, 'vitamin D binding protein ...'), ('CHEBI_27300', 'vitamin D', 492, 'vitamin D'), ('PR_000008467', 'hemoglobin subunit zeta', 512, 'Haptoglobin2Fe'), ('GO_0051235', 'maintenance of location', 527, 'sequestration'), ('PR_000008446', 'hyaluronan and proteoglycan link protein 3', 541, 'Hemopexin2Fe'), ('GO_0051235', 'maintenance of location', 554, 'sequestration'), ('PR_000008450', 'hyaluronan synthase 2', 568, 'Hepcidin'), ('CHEBI_65381', 'albizoside C', 577, 'antimicrobial'), ('GO_0051235', 'maintenance of location', 602, 'sequestration'), ('CHEBI_75902', 'hispidulin', 616, 'Histidine'), ('CHEBI_35318', 'glycosylmannose', 631, 'glycoproteinHemostasis'), ('PR_000009670', 'La-related protein 4', 654, 'Lactoferrin2Fe'), ('GO_0051235', 'maintenance of location', 669, 'sequestration'), ('CHEBI_16412', 'lipopolysaccharide', 683, 'LPS'), ('CHEBI_31005', 'manninotriose', 741, 'Mannose'), ('PR_000010490', 'neutrophil collagenase', 741, 'Mannose-binding lectin ...'), ('PR_000000364', 'smad2', 828, 'Serum amyloid A1Chemoattractant'), ('UBERON_0001977', 'blood serum', 828, 'Serum'), ('CHEBI_60425', 'amyloid fibril', 834, 'amyloid'), ('UBERON_0001977', 'blood serum', 860, 'Serum'), ('CHEBI_60425', 'amyloid fibril', 866, 'amyloid'), ('PR_000004770', 'Polycomb complex protein BMI-1', 908, 'B-12'), ('PR_000017409', 'protein WFDC13', 927, 'Willebrand'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 963, 'Albumin2Oncotic'), ('CHEBI_18059', 'lipid', 989, 'lipid'), ('GO_0010351', 'lithium ion transport', 989, 'lipid transport')]
PMC4448820	5/2015	S1106-PMC4448820	['studies USUALLY DESCRIBE HOW infection and inflammation are ASSOCIATED with nutritional deficiencies [e.g., iron, Vitamin B-12, Folate, and Vitamin D for bacterial vaginosis (637–639) and anemia or obesity for stillbirths (640)].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4516377	6/2015	S0-PMC4516377	['Calcium intake, Serum Vitamin D and obesity in children: IS there an ASSOCIATION?']	[('EXPLICIT_QUESTION', 57), ('SUPERFICIAL_RELATIONSHIP', 69), ('EXPLICIT_QUESTION', 80)]	3	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('UBERON_0001977', 'blood serum', 16, 'serum'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4592566	10/2015	S166-PMC4592566	['HOW about Vitamin D?”\nr: “no.”\ninterviewer: “iron.”\nr: “no.”\ninterviewer: “omega 3.”\nr: “no.”\ninterviewer: “vitamin c or zinc.”\nr: “no.”\ninterviewer: “right.']	[('EXPLICIT_QUESTION', 0)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4595656	10/2015	S19-PMC4595656	['the QUESTION of reduced Vitamin D concentrations on consequent neonatal, infant and child Development in RELATION to the hippocampus is THEREFORE HIGHLY PERTINENT.']	[('EXPLICIT_QUESTION', 4), ('SUPERFICIAL_RELATIONSHIP', 105), ('PROBABLE_UNDERSTANDING', 136), ('IMPORTANT_CONSIDERATION', 146)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0048513', 'animal organ development', 90, '... development')]
PMC4598849	10/2015	S9-PMC4598849	['WHETHER the common Vitamin D deficiency during Pregnancy CONTRIBUTES to any of the GLOBAL adverse fetal growth epidemic REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 83), ('FULL_UNKNOWN', 120)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4689556	12/2015	S165-PMC4689556	['), there REMAINS an IMPORTANT QUESTION WHETHER Prenatal Vitamin D supplementation at doses which reliably achieve sufficiency in the target population, CAN improve healthcare outcomes for young children.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 20), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('EXPLICIT_QUESTION', 39), ('INCOMPLETE_EVIDENCE', 152)]	6	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4764019	1/2016	S51-PMC4764019	['CAN it be that Vitamin D inadequacy CONTRIBUTES to the disease BURDEN of so many otherwise UNRELATED disorders?']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 91), ('EXPLICIT_QUESTION', 110)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]
PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4765528	12/2015	S118-PMC4765528	['early work on methylation and Vitamin D Receptors and Placental calcium transporters SUGGESTS that epigenetic Regulation MIGHT explain HOW maternal Vitamin D levels AFFECT bone mineralization in the neonate [51].']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 121), ('EXPLICIT_QUESTION', 135), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 30, 'vitamin D receptors'), ('UBERON_0001987', 'placenta', 54, 'placental'), ('GO_0065007', 'biological regulation', 110, 'regulation'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]
PMC4889866	5/2016	S23-PMC4889866	['in addition, we SOUGHT TO INVESTIGATE WHETHER maternal Blood and Cord Blood Vitamin D CORRESPOND in their ASSOCIATION with tlr-related Innate Immunity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('EXPLICIT_QUESTION', 38), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0045087', 'innate immune response', 135, 'innate immunity')]
PMC4889866	5/2016	S126-PMC4889866	['THUS, our data could NOT provide detailed mechanism on HOW maternal Vitamin D level AFFECTED neonatal tlr-triggered Il-10 Response.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('EXPLICIT_QUESTION', 55), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 116, 'IL-10'), ('GO_1990603', 'dark adaptation', 118, '- ... response')]
PMC4930210	7/2016	S13-PMC4930210	['CURRENTLY, there is a LACK OF CONSENSUS on WHAT constitutes Vitamin D sufficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 22), ('EXPLICIT_QUESTION', 43)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4934634	11/2015	S13-PMC4934634	['HOWEVER, the prevalence of Vitamin D deficiency is a subject of intense DEBATE, IN PART DUE TO DIFFERENCES of opinion regarding WHAT actually constitutes a “deficiency”.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('EXPLICIT_QUESTION', 128)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]
PMC4934634	11/2015	S252-PMC4934634	['similarly, STUDIES ARE NEEDED to address WHETHER women who are Vitamin D sufficient at Conception and receiving high doses of Vitamin D (≥4000 iu/daily) have adverse Pregnancy outcomes.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007620', 'copulation', 87, 'conception'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S291-PMC4934634	['with large percentages of Individuals having INSUFFICIENT Vitamin D levels, this RAISES the QUESTION of WHETHER fortification EFFORTS SHOULD BE increased.']	[('IMPORTANT_CONSIDERATION', 45), ('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('EXPLICIT_QUESTION', 104), ('FUTURE_WORK', 126), ('FUTURE_WORK', 134)]	7	[('NCBITaxon_1', 'root', 26, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC4989298	8/2016	S355-PMC4989298	['IS the administration of Vitamin D RECOMMENDED during Pregnancy to prevent allergic diseases in children?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 35), ('EXPLICIT_QUESTION', 104)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy')]
PMC4989298	8/2016	S357-PMC4989298	['IS the administration of Vitamin D in doses higher than RECOMMENDED intakes for the first year of Life RECOMMENDED for the prevention of allergic diseases?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 56), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 154)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life')]
PMC4989298	8/2016	S359-PMC4989298	['IS the administration of Vitamin D in doses compliant with RECOMMENDED intakes SUGGESTED for the first year of Life RECOMMENDED for the prevention of allergic disease?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 116), ('EXPLICIT_QUESTION', 166)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4997421	8/2016	S139-PMC4997421	['MORE RESEARCH IS NEEDED to determine WHAT type of INTERVENTIONS will be best for specific populations, ESPECIALLY the low-income and minority populations that bear a greater BURDEN of Vitamin A inadequacy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('EXPLICIT_QUESTION', 37), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 174)]	6	[('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 192, 'A')]
PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5014971	8/2016	S35-PMC5014971	['HOWEVER, CONSENSUS on WHAT constitutes adequate Vitamin D status during Pregnancy and the most efficacious means to prevent and treat Vitamin D deficiency/insufficiency in Pregnant women has yet to be reached, leading to DIFFERING assessments of this PUBLIC HEALTH ISSUE [14,19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('EXPLICIT_QUESTION', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('IMPORTANT_CONSIDERATION', 251), ('IMPORTANT_CONSIDERATION', 265)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnant')]
PMC5028238	10/2016	S85-PMC5028238	['this HAS BEEN used TO EXPLAIN WHY northern populations have a higher prevalence of slos.11\ncarriers also are HYPOTHESIZED to have a Reproductive advantage because of the reduced fetal death due to Rachitic Cephalopelvic disproportion.11,35this is again RELATED to increased Vitamin D Production causing improved bone formation.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('PROBABLE_UNDERSTANDING', 22), ('EXPLICIT_QUESTION', 30), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('GO_0000003', 'reproduction', 132, 'reproductive'), ('UBERON_0001286', "Bowman's space", 197, 'rachitic cephalopelvic'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 284, 'production')]
PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5062906	10/2016	S243-PMC5062906	['WHILE maternal Vitamin D deficiency resulted in both phenotypic and epigenetic changes in both generations, it REMAINS UNCLEAR WHETHER the Dna Methylation changes are causally LINKED to the phenotypic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('EXPLICIT_QUESTION', 127), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0006306', 'DNA methylation', 139, 'DNA methylation')]
PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5129897	10/2016	S17-PMC5129897	['a review of clinical trials of Vitamin D with respect to biomarkers of inflammation SHOWS WHY following those guidelines is IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 84), ('EXPLICIT_QUESTION', 90), ('IMPORTANT_CONSIDERATION', 124)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5146866	12/2016	S10-PMC5146866	['OUR FINDINGS RAISE a QUESTION regarding the adequacy of the aap RECOMMENDED Vitamin D supplementation REQUIREMENTS without knowing the infant’s Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('EXPLICIT_QUESTION', 21), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth')]
PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
PMC5155676	12/2016	S23-PMC5155676	['clinically, understanding HOW Individuals respond COULD LEAD to individualized Antenatal counseling regarding Vitamin D supplementation to ensure Vitamin D repletion is achieved without increasing the RISK of Vitamin D toxicity.']	[('EXPLICIT_QUESTION', 26), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 201)]	4	[('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0007567', 'parturition', 79, 'antenatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5325195	2/2017	S93-PMC5325195	['cbhvs also actively promoted facility-based delivery.10.1371/journal.pone.0170739.t001\n\ncaption (table-wrap): table 1\ncbhv messages to Pregnant women transmitted through pictorial counselling cards.1 importance of Antenatal clinic attendance for Pregnant women 2 importance of screening tests, including hiv in Pregnancy 3 importance of intermittent preventive therapy for malaria in Pregnancy using Sulphadoxine-Pyrimethamine tablets 4 importance of skilled attendance in Labor and Postpartum care 5 importance of an Insecticide-treated net and HOW to use it at home 6 types of Food, importance of an adequate and balanced diet in Pregnancy, and Vitamin A supplementation for children 7 the IMPORTANCE of iron and Folic Acid during Pregnancy 8 importance of using Misoprostol tablets after Delivery Of the Baby and HOW to use it 9 the IMPORTANCE of Chlorhexidine gel for Cord care and HOW to apply it on the Cord; avoiding use of POTENTIALLY harmful substances to the Cord 10 the care for low Birth weight babies with kangaroo care 11 HOW to prepare the Oral rehydration Solution (ors) for diarrheal diseases in children under 5 years, and the IMPORTANCE of ors.']	[('EXPLICIT_QUESTION', 546), ('IMPORTANT_CONSIDERATION', 692), ('EXPLICIT_QUESTION', 816), ('IMPORTANT_CONSIDERATION', 836), ('EXPLICIT_QUESTION', 886), ('INCOMPLETE_EVIDENCE', 931), ('EXPLICIT_QUESTION', 1036), ('IMPORTANT_CONSIDERATION', 1145)]	8	[('GO_0007565', 'female pregnancy', 135, 'pregnant'), ('GO_0007567', 'parturition', 214, 'antenatal'), ('GO_0007565', 'female pregnancy', 246, 'pregnant'), ('GO_0007565', 'female pregnancy', 311, 'pregnancy'), ('GO_0007565', 'female pregnancy', 384, 'pregnancy'), ('CHEBI_9329', 'sulfadoxine', 400, 'Sulphadoxine'), ('CHEBI_16610', 'spermidine', 413, 'pyrimethamine'), ('GO_0007612', 'learning', 473, 'labor'), ('GO_0007565', 'female pregnancy', 483, 'postpartum'), ('CHEBI_24852', 'insecticide', 518, 'insecticide'), ('CHEBI_33290', 'food', 579, 'food'), ('GO_0007565', 'female pregnancy', 632, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin A'), ('CHEBI_30751', 'formic acid', 715, 'folic acid'), ('GO_0007565', 'female pregnancy', 733, 'pregnancy'), ('CHEBI_63610', 'misoprostol', 765, 'misoprostol'), ('GO_0046697', 'decidualization', 791, 'delivery of ... baby'), ('CHEBI_3647', 'chlorpromazine', 850, 'chlorhexidine'), ('UBERON_0002240', 'spinal cord', 872, 'cord'), ('UBERON_0002240', 'spinal cord', 909, 'cord'), ('UBERON_0002240', 'spinal cord', 969, 'cord'), ('GO_0007567', 'parturition', 994, 'birth'), ('UBERON_0000978', 'leg', 1055, 'Oral'), ('CHEBI_75958', 'solution', 1072, 'Solution')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5474873	6/2017	S186-PMC5474873	['HOWEVER, there is a LACK OF PREVIOUS STUDIES on HOW sun exposure, the main source of Vitamin D, INFLUENCES psychotic experiences in the general population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 48), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5513133	7/2017	S30-PMC5513133	['WHILE the pathogenesis of pe INVOLVES a number of biological Processes, there are several HYPOTHESES to SUGGEST HOW Vitamin D levels MAY AFFECT these processes (table1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 112), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('GO_0007565', 'female pregnancy', 61, 'processes'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5513133	7/2017	S92-PMC5513133	['methods\n\nsearch strategy\nthe review protocol was designed a priori to answer the QUESTION, “WHAT are the EFFECTS of Vitamin D concentrations and supplementation during Pregnancy on pre-eclampsia in women?” we conducted a literature search using medline electronic databases (via pubmed) to identify published studies until february 2015.']	[('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy')]
PMC5513133	7/2017	S233-PMC5513133	['studies MUST ALSO BE interpreted according to HOW Vitamin D exposure is defined and measured.']	[('IMPORTANT_CONSIDERATION', 8), ('EXPLICIT_QUESTION', 46)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5521778	7/2017	S137-PMC5521778	['suppression of Bco1 Expression and activity by Glucocorticoids\nsince Retinoids (Vitamin A) and Gcs play INTERACTIVE ROLES in Lung Development and Regeneration [40], we ASKED WHETHER gcs alter Carotenoid-to-Retinoid Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('EXPLICIT_QUESTION', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174)]	4	[('PR_000004693', 'Bcl-2-like protein 10', 15, 'BCO1'), ('GO_0010467', 'gene expression', 20, 'expression'), ('CHEBI_36597', 'phthalazine', 47, 'glucocorticoids'), ('CHEBI_26537', 'retinoid', 69, 'retinoids'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CL_0000740', 'retinal ganglion cell', 95, 'GCs'), ('GO_0060424', 'lung field specification', 125, 'lung development ... regeneration'), ('UBERON_0002048', 'lung', 125, 'lung'), ('CHEBI_23044', 'carotenoid', 192, 'carotenoid'), ('GO_0016116', 'carotenoid metabolic process', 192, 'carotenoid- ... metabolism'), ('CHEBI_26537', 'retinoid', 206, 'retinoid')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5956785	5/2018	S30-PMC5956785	['HERE we report the results of a Vitamin D- jia scoping review that summarizes, synthesizes, evaluates, and interprets pertinent EVIDENCE from the literature to address the following research questions: 1) WHAT is the RELATIONSHIP between Vitamin D status and the occurrence of jia?']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 128), ('EXPLICIT_QUESTION', 205), ('SUPERFICIAL_RELATIONSHIP', 217), ('EXPLICIT_QUESTION', 280)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5956785	5/2018	S31-PMC5956785	['2) WHAT is the RELATIONSHIP between Vitamin D status and childhood arthritis activity?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 85)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S32-PMC5956785	['3) WHAT is the RELATIONSHIP between Vitamin D status in jia and medication use?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S33-PMC5956785	['4) WHAT is the RELATIONSHIP between Vitamin D status and geographic and demographic characteristics in children with jia?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 120)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S251-PMC5956785	['RECENTLY THE IDEA of investigating epistasis (Gene-Gene interactions) amongst Genes in the inflammatory and Vitamin D pathway and HOW their INTERACTIONS CONTRIBUTE to jia risk was explored by ellis et al.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 130), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('SO_0000704', 'gene', 46, 'gene'), ('SO_0000704', 'gene', 51, 'gene'), ('SO_0000704', 'gene', 78, 'genes'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC5956785	5/2018	S256-PMC5956785	['also HOW they IMPACT the biological Response involving Vitamin D and inflammation REMAINS UNCLEAR.']	[('EXPLICIT_QUESTION', 5), ('SUPERFICIAL_RELATIONSHIP', 14), ('FULL_UNKNOWN', 82)]	3	[('GO_0060033', 'anatomical structure regression', 36, 'response'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5956785	5/2018	S280-PMC5956785	['we do not, HOWEVER, know the optimal Vitamin D status for children with jia, WHETHER reduced Vitamin D is caused by increased utilization OR reduced Vitamin D status in children with jia, the IMPACT of Vitamin D in disease activity or the ROLE of Vdr polymorphisms with jia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('EXPLICIT_QUESTION', 77), ('SUPERFICIAL_RELATIONSHIP', 192), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 247, 'VDR')]
PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC6011374	6/2018	S1-PMC6011374	['hence, there is CONTINUING INTEREST in determining HOW Vitamin D INFLUENCES Pregnancy health.']	[('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 51), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC6011374	6/2018	S10-PMC6011374	['a POSSIBLE ASSOCIATION between fetal sex, Vitamin D status and gdm provides FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 76), ('EXPLICIT_QUESTION', 84), ('FUTURE_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC6011374	6/2018	S12-PMC6011374	['background\nwith an increasing prevalence of Vitamin D deficiency and insufficiency reported both in australia and new zealand, as well as worldwide [1], there is CONTINUING INTEREST in determining HOW Vitamin D deficiency MAY INFLUENCE health in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 162), ('EXPLICIT_QUESTION', 197), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S121-PMC6011374	['HOWEVER, DIFFERENCES in Vitamin D status between the women recruited in adelaide and those recruited in auckland reflect obvious DIFFICULTIES in studying HOW Vitamin D MAY support healthy Pregnancies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('DIFFICULT_TASK', 129), ('EXPLICIT_QUESTION', 154), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancies')]
